ZEDI
Live / Registered — Registered and renewed (as of 03 Jun 2021)
What this means for you
Registered since 08 Mar 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Mar 2021).
Record
- Serial number
- 77837613
- Registration number
- 3927419
- Mark type
- Design + words
- Filed
- 29 Sept 2009
- Published for opposition
- 21 Dec 2010
- Registered
- 08 Mar 2011
- Next maintenance due
- 08 Mar 2021
- Attorney of record
- Dwayne K. Goetzel
Goods and services
- Class 001 — Chemicals: Chemical and biochemical products, namely, chemicals, chemical preparations, biochemical preparations for industrial or scientific purposes
- Class 005 — Pharmaceuticals: [ (( Medicines for the treatment of celiac diseases, autoimmune diseases, food intolerances, intestinal diseases, irritable bowel syndrome, fibrosis, scarring, hypertrophic scars, scleroderma, diabetic nephropathy, hepatic fibrosis, cirrhosis, pulmonary fibrosis, atherosclerosis, cancer, thrombolytic therapy, acne, skin aging, psoriasis, neurodegenerative diseases, Alzheimer's disease, Huntington's diseases, Parkinson's disease, cataracts, affection by microorganisms, infections or candidiasis; pharmaceutical and veterinary medical products, namely, preparations for healthcare for the treatment of celiac diseases, autoimmune diseases, food intolerances, intestinal diseases, irritable bowel syndrome, fibrosis, scarring, hypertrophic scars, scleroderma, diabetic nephropathy, hepatic fibrosis, cirrhosis, pulmonary fibrosis, atherosclerosis, cancer, thrombolytic therapy, acne, skin aging, psoriasis, neurodegenerative diseases, Alzheimer's disease, Huntington's diseases, Parkinson's disease, cataracts, affection by microorganisms, infections or candidiasis; preparations or pharmaceuticals, namely, for the treatment and prophylaxis of celiac diseases, autoimmune diseases, food intolerances, intestinal diseases, irritable bowel syndrome, fibrosis, scarring, hypertrophic scars, scleroderma, diabetic nephropathy, hepatic fibrosis, cirrhosis, pulmonary fibrosis, atherosclerosis, cancer, thrombolytic therapy, acne, skin aging, psoriasis, neurodegenerative diseases, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, bacterial or yeast infection, infections, or candidiasis; chemical and biochemical products, namely, chemical preparations in the nature of chemical reagents and biochemical preparations for medical purposes; chemical and biochemical products, namely, chemical preparations in the nature of chemical reagents and biochemical preparations for healthcare; chemical and biochemical products, namely, chemical preparations in the nature of chemical reagents and biochemical preparations for human and veterinary medical use; dietetic products, namely, dietary supplements, dietetic foods adapted for medical use; dietetic products, namely, dietary supplements, dietetic foods adapted for healthcare; dietetic products, namely, dietary supplements, dietetic foods adapted for human and veterinary medical use; dietary supplements for medical purposes; disinfectants for medical instruments, for hygienic purposes, for sanitary purposes; preparations for destroying vermin; chemical and biochemical products for medical science for use in or on the human or animal body, namely, biochemical preparations and chemical reagents; diagnostic agent for medical purposes; X-ray contrast agent for medical purposes; germicidal detergents for medical purposes )) ]
- Class 042 — Scientific and technological services: Commissioned research in the field of medical research, medical devices and biological research; conducting research and development work in the medical, pharmaceutical, pharmacological, biochemical and/or medicine technological area on behalf of third parties; commissioned execution of clinical trials and clinical studies in the field of medical and scientific research; commissioned assessment of scientific projects in the field of quality assessment and evaluation, commissioned evaluation of clinical trials and studies in the field of quality assessment and evaluation; services of a biochemical laboratory; services of an analytical laboratory in the field of medical, biological and chemical
Owner
- Zedira GmbH, Darmstadt, DE
- Zedira GmbH, 64293 Darmstadt, DE
- Zedira GmbH, 64293 Darmstadt, DE
Prosecution history
- 04 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 03 Jun 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 03 Jun 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Feb 2021 — TEAS SECTION 8 & 9 RECEIVED
- 08 Mar 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Jun 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 05 Jun 2018 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
- 31 May 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 06 Apr 2018 — POST REGISTRATION ACTION MAILED - SEC. 8
- 06 Apr 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Jan 2017 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
- 19 Jan 2017 — REGISTERED - SEC. 15 ACKNOWLEDGED
- 19 Jan 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Dec 2016 — TEAS SECTION 15 RECEIVED